(Q38030830)

27 August 2017

title

Diagnosis and management of Chagas disease and cardiomyopathy (English)

1 reference

27 August 2017

0 references

Antonio L Ribeiro

1

0 references

Mauro M Teixeira

series ordinal

3

object named as

Mauro M Teixeira

1 reference

27 August 2017

Maria P Nunes

2

1 reference

27 August 2017

Manoel O C Rocha

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

31 July 2012

1 reference

Nature Reviews Cardiology

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

576-589

1 reference

on focus list of Wikimedia project

27 August 2017

ScienceSource

0 references

cites work

Chagas disease: a Latin American health problem becoming a world health problem

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

An update on the management of Chagas cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas cardiomyopathy--where do we stand after a hundred years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Physician awareness of Chagas disease, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease: a new worldwide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Measures to prevent transfusion-associated protozoal infections in non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Clinical and epidemiological aspects of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Oral transmission of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Laboratory-acquired parasitic infections from accidental exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The future of Chagas disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Risks of endemicity, morbidity and perspectives regarding the control of Chagas disease in the Amazon Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Epidemiology of Chagas disease in non-endemic countries: the role of international migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Trypanosoma cruzi and Chagas' Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Inflammation and Chagas disease some mechanisms and relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The role of parasite persistence in pathogenesis of Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Mechanisms of Trypanosoma cruzi persistence in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The clinical immunology of human Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The vasculature in chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Acute and congenital Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

New drugs for neglected infectious diseases: Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease: 100 years after its discovery. A systemic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The indeterminate form of human chronic Chagas' disease A clinical epidemiological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The Valsalva maneuver in Chagas disease patients without cardiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease: what is known and what is needed--a background article

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Clinical management of chronic Chagas cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Clinical predictors of chronic chagasic myocarditis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Sudden cardiac death in patients with chagas heart disease and preserved left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Development and validation of a risk score for predicting death in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Holter monitoring in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Predictors of mortality in chronic Chagas disease: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Prognostic value of signal-averaged electrocardiogram in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Clinical and electrophysiologic features of syncope in chronic chagasic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Echocardiographic parameters associated with pulmonary congestion in Chagas cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Echocardiography in Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Peculiar aspects of cardiogenic embolism in patients with Chagas' cardiomyopathy: a transthoracic and transesophageal echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Morbidity and prognostic factors in chronic chagasic cardiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Correlation between BNP levels and Doppler echocardiographic parameters of left ventricle filling pressure in patients with Chagasic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Left ventricular diastolic function and exercise capacity in patients with Chagas cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Detection of early right ventricular dysfunction in Chagas' disease using Doppler tissue imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Morphofunctional characteristics of the right ventricle in Chagas' dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Functional capacity and right ventricular function in patients with Chagas heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Cardiac magnetic resonance in Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Cost-benefit of the telecardiology service in the state of Minas Gerais: Minas Telecardio Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Mortality indicators among chronic Chagas patients living in an endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

T-wave amplitude variability and the risk of death in Chagas disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Prognostic value of exercise-induced ventricular arrhythmia in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Nonlinear mathematical model for predicting long term cardiac remodeling in Chagas' heart disease: introducing the concepts of 'limiting cardiac function' and 'cardiac function deterioration period'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Antitrypanosomal therapy for chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease: pushing through the pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Antitrypanosomal agents: treatment or threat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Cell-based therapy in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

A randomized trial of the effects of exercise training in Chagas cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas' disease and the use of implantable cardioverter-defibrillators in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Medical treatment of cardiac arrhythmias in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas' disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas' VT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas Disease Predicts 10-Year Stroke Mortality in Community-Dwelling Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease and mortality in old age as an emerging issue: 10 year follow-up of the Bambuí population-based cohort study (Brazil)

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

Tissue Doppler imaging in the evaluation of the regional diastolic function in chagas' disease

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

The Valsalva maneuver in Chagas disease patients without cardiopathy

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

The prognostic significance of electrocardiographic changes in Chagas disease

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

Associação entre dissinergia miocárdica e arritmia ventricular na forma indeterminada da doença de Chagas

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas’ disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

Diastolic function in Chagas' disease: an echo and tissue Doppler imaging study

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

Risk estimation approach in Chagas disease is still needed

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

12 December 2020

A Risk Score for Predicting Death in Chagas' Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

21 January 2018

Response to the Editor:

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease in the Amazon region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The current screening programme for congenital transmission of Chagas disease in Catalonia, Spain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas disease in the immunosuppressed host

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

[Indeterminate form of Chagas disease: considerations about diagnosis and prognosis]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Dysautonomia and ventricular dysfunction in the indeterminate form of Chagas disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

31 March 2020

Chagas' heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Ventricular arrhythmias and left ventricular myocardial function in chronic chagasic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

[Clinical profile of Chagas and non-Chagas' disease patients with cardiac pacemaker]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Value of the radiological study of the thorax for diagnosing left ventricular dysfunction in Chagas' disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Stroke in asymptomatic Trypanosoma cruzi-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chronic renal impairment in patients with Chagas cardiomyopathy with chronic systolic heart failure: prevalence and prognostic significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Two approaches to discovering and developing new drugs for Chagas disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Chagas' disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Heart transplantation in 107 cases of Chagas' disease

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

31 March 2020

12 December 2020

Heart failure during cardiac pacing

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.109

Benznidazole and Chagas disease: can an old drug be the answer to an old problem?

31 March 2020

1 reference

12 December 2020

Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis

1 reference

12 December 2020

THE ELECTROCARDIOGRAM IN THE PROGNOSIS AND EVOLUTION OF CHAGAS' DISEASE

1 reference

12 December 2020

[Indeterminate form of Chagas' disease. Proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy]

1 reference

12 December 2020

[Brazilian Consensus on Chagas disease]

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

A risk score for predicting death in Chagas' heart disease

1 reference

12 December 2020

Pathogenesis of Chagas disease: time to move on.

1 reference

12 December 2020

Radionuclide angiographic evidence for early predominant right ventricular involvement in patients with Chagas' disease

1 reference

12 December 2020

Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease

1 reference

12 December 2020

[Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features]

1 reference

12 December 2020

Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community

1 reference

12 December 2020

Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy

1 reference

12 December 2020

Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form

1 reference

12 December 2020

1 reference

12 December 2020

[Natural history of Chagas disease]

1 reference

12 December 2020

Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy

1 reference

12 December 2020

The Southern Cone Initiative against Chagas disease

1 reference

12 December 2020

The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease

1 reference

12 December 2020

1 reference

12 December 2020

[Chronotropic-metabolic index in Chagas' disease]

1 reference

12 December 2020

Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas' disease: assessment by dobutamine stress echocardiography

1 reference

12 December 2020

Sudden death in Chagas' disease

1 reference

12 December 2020

Chagas disease in European countries: the challenge of a surveillance system.

1 reference

12 December 2020

Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui cohort study of aging

1 reference

12 December 2020

10.1038/NRCARDIO.2012.109

Identifiers

DOI

1 reference

27 August 2017

1 reference